Stocks股票 / Health Care / ENOV

Enovis · Health Care

ENOV US listed · USD美股 · 美元

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司(Enovis Corporation)是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司(Colfax Corporation)之名创立。

Small cap小盘 · $2B Speculative / unprofitable投机/未盈利 Health Care S&P 600标普600小盘Russell 2000罗素2000
$26.84
-$0.23 · -0.85%
52w low52周低 $19.30high $33.93
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤 Confirmed cycle low — the entry window is open now, with a clear exit if it closes back below 20.04.周期低点已确认——入场窗口现已开启,若收盘重新跌破 20.04 则明确离场。 Engine read引擎解读 · 2026-07-21

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动

Technicals技术面

daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量(RSI 14) 59
Neutral zone中性区域
vs 50-day average相对50日均线 +13.0% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +4.8% above上方 Long trend up长期向上
Volatility波动率 99th percentile第99百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-08-06
17days to go天后公布

Estimates being raised — 10 analysts预期上调 — 10 位分析师

Valuation估值

Looks cheap vs sector相对行业偏便宜
Multiple指标ENOV Sector median行业中位Cheaper than相对便宜
P/B市净率 1.03x 3.44 97%
P/S市销率 0.68x 2.97 89%
Earnings yield盈利收益率 -77.16% 2.72 2%
FCF yield自由现金流收益率 1.30% 4.00 19%
Shareholder yield股东收益率 0.23% 1.89 17%
EV/EBITDA企业价值/EBITDA 12.71x 18.18 74%
P/FCF市值/自由现金流 77.08x 22.08 7%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入
$3.1B2020
$3.9B2021
$1.6B2022
$1.7B2023
$2.1B2024
$2.2B2025
5-yr growth5年复合增速 -6.0%
Earnings per share每股收益
$0.312020
$0.462021
$-0.252022
$-0.612023
$-14.932024
$-20.752025
Free cash flow自由现金流
$187.2M2020
$251.9M2021
-$161.3M2022
$12.8M2023
-$67.2M2024
$19.9M2025
Gross margin毛利率
59.8%
Operating margin营业利润率
-50.0%
Net margin净利率
-52.7%
FCF margin自由现金流利润率
9.7%
Balance-sheet quality财务体质 4/9 Bankruptcy risk: distress zone破产风险:警戒区 Return on equity股本回报率 -80% Watch关注

Leverage杠杆

Net debt / EBITDA净债务/EBITDA5.73
Current ratio流动比率2.02

Capital allocation资本配置

Stock-based comp股权薪酬$32.9M
Share count change (1y)股数变化(1年)+2.4%

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 BUY ZONE → BOTTOMING买入区 → 筑底中

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: +$0.2M net (2 buyers, 1 sellers)+$0.2M 净值(2 买家,1 卖家)

Fund基金Grade评级 Latest move最新动作% of book组合占比As of截至
Dorsey Asset Management B exitexit 0.0% 2026-03-31

Signal history信号历史

engine events引擎事件
BOTTOMING → BUY ZONE筑底中 → 买入区 BUY. New daily cycle, day 12: swing low in, price back above the 10-day average, daily momentum positive — and the weekly timeframe agrees. Last cycle was left-translated (topped early) — a bearish structural tell买入。新的日线周期,第 12 天:摆动低点已现,价格重新站上 10 日均线,日线动量为正——且周线周期也一致确认。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
Jul 16, 2026
BUY ZONE → BOTTOMING买入区 → 筑底中
BUY SETUP买入预备
Jul 16, 2026
ENOV reclaimed its 200-day averageENOV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $28.07.收盘重回200日均线 — 经典的多头分界线。$28.07。
Jul 16, 2026
ENOV took relative-strength leadershipENOV 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $28.07.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$28.07。
Jul 15, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 14, 2026
ENOV lost its 200-day averageENOV 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $24.65.收盘跌破200日均线 — 经典的空头分界线。$24.65。
Jul 10, 2026
ENOV reclaimed its 200-day averageENOV 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $25.75.收盘重回200日均线 — 经典的多头分界线。$25.75。
Jul 9, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 8, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
ENOV lost its 200-day averageENOV 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $25.52.收盘跌破200日均线 — 经典的空头分界线。$25.52。
Showing the last 15 of显示最近15条,共 255 signals条信号

Company profile公司档案

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司(Enovis Corporation)是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司(Colfax Corporation)之名创立。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Above market高于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-07-21 · regenerated nightly每晚更新 · Generated生成于 2026-07-21 02:08 UTC · All coverage所有股票 · Analyzer分析器